Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines

International Journal of Infectious Diseases

Volumn 14, Issue 9, 2010, Pages

  Bours, P H A ^a   Polak, R ^a   Hoepelman, A I M ^a   Delgado, E ^b   Jarquin, A ^b   Matute, A J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Universidad Nacional Autónoma de Nicaragua   (Nicaragua)

Author keywords

Antibiotics; Epidemiology; Extended spectrum beta lactamase; Resistance; Urinary tract infections

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFTRIAXONE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; NITROFURANTOIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACINETOBACTER; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHILD; COMMUNITY CARE; CYSTITIS; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HEALTH CARE PLANNING; HUMAN; KLEBSIELLA; KLUYVERA; MAJOR CLINICAL STUDY; MALE; PROTEUS MIRABILIS; PYELONEPHRITIS; SCHOOL CHILD; SERRATIA; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL; URETHRITIS; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEALTH POLICY; HUMANS; LATIN AMERICA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NICARAGUA; PROGRAM EVALUATION; RISK FACTORS; SERRATIA; SERRATIA INFECTIONS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 77956613458     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.02.2264     Document Type: Article

References (27)

1. Matute A.J., Hak E., Schurink C.A., McArthur A., Alonso E., Paniagua M., et al. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents 2004, 23:506-509.
2. Gales A.S., Sader H.S., Jones R.N. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002, 44:289-299. SENTRY Participants Group (Latin America).
3. Andrade S.S., Sader H.S., Jones R.N., Pereira A.S., Pignatari A.C., Gales A.C. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?. Mem Inst Oswaldo Cruz 2006, 101:741-748.
4. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999, 29:745-758.
5. Bean D., Krahe D., Wareham D.W. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008, 7:13.
6. Akram M., Shahid M., Khan A.U. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007, 6:4.
7. Gupta K., Sahm D.F., Mayfield D., Stamm W.E. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001, 33:89-94.
8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl):5S-13S.
9. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000, 10:509-515.
10. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992, 15(Suppl 1):S216-S227.
11. Rubenstein J.N., Schaeffer A.J. Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am 2003, 17:333-351.
12. European Confederation of Laboratory Medicine. European urinalysis guidelines: summary. Scand J Clin Lab Invest 2000; 60:1-96.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. M100-S18. Wayne, PA: CLSI; 2008.
14. Su L.H., Ou J.T., Leu H.S., Chiang P.C., Chiu Y.P., Chia J.H., et al. Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol 2003, 41:4726-4732.
15. Kim B.N., Choi S.I., Ryoo N.H. Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit. J Korean Med Sci 2006, 21:973-978.
16. Villegas M.V., Correa A., Perez F., Miranda M.C., Zuluaga T., Quinn J.P., et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004, 49:217-222.
17. Savini V., Catavitello C., Talia M., Manna A., Pompetti F., Favaro M., et al. Multidrug-resistant Escherichia fergusonii: a case of acute cystitis. J Clin Microbiol 2008, 46:1551-1552.
18. Mahapatra A., Mahapatra S., Mahapatra A. Escherichia fergusonii: an emerging pathogen in South Orissa. Indian J Med Microbiol 2005, 23:204.
19. Rossi F., García P., Ronzon B., Curcio D., Dowzicky M.J. Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 2008, 12:405-415.
20. Miller L.G., Tang A.W. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004, 79:1048-1054.
21. Hooton T.M., Besser R., Foxman B., Fritsche T.R., Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004, 39:74-80.
22. Gupta K., Hooton T.M., Roberts P.L., Stamm W.E. Short-course nitrofurantoin for the treatment of uncomplicated cystitis in women. Arch Intern Med 2007, 167:2207-2212.
23. Kashanian J., Hakimiam P., Blute M., Wong J., Khanna H., Wise G., Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 2008, 102:1634-1637.
24. Hooton T.M. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 2003, 22(Suppl 2):S65-72.
25. Hummers-Pradier E., Kochen M.M. Urinary tract infections in adult general practice patients. Br J Gen Pract 2002, 52:752-761.
26. Naber K.G., Bergman B., Bishop M.C., Bjerklund-Johansen T.E., Botto H., Lobel B., et al. EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 2001, 40:576-588.
27. Nickel J.C. Management of urinary tract infections: historical perspective and current strategies: part 2-modern management. J Urol 2005, 173:27-32.